Use of cell-free non-invasive prenatal testing in pregnancies affected by placental mosaicism.

CfNIPT has a low detection rate of mosaicism, including pregnancies with clinically significant mosaicism. However, abnormal cfNIPT results may be a predictor of adverse pregnancy outcomes.